VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 39 filers reported holding VAXCYTE INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,220,795,855 | +9.9% | 16,167,340 | -0.6% | 0.08% | +4.0% |
Q1 2024 | $1,110,799,797 | +24.4% | 16,261,159 | +14.4% | 0.08% | +8.7% |
Q4 2023 | $892,599,345 | +24.4% | 14,213,365 | +1.0% | 0.07% | +11.3% |
Q3 2023 | $717,647,365 | +2.2% | 14,077,037 | +0.1% | 0.06% | +5.1% |
Q2 2023 | $701,968,411 | -20.7% | 14,056,236 | -40.5% | 0.06% | +47.5% |
Q1 2023 | $885,170,052 | +81.5% | 23,617,130 | +132.2% | 0.04% | -16.7% |
Q4 2022 | $487,617,048 | +128.4% | 10,169,282 | +14.3% | 0.05% | +118.2% |
Q3 2022 | $213,533,000 | +15.3% | 8,897,197 | +4.5% | 0.02% | +22.2% |
Q2 2022 | $185,253,000 | -8.4% | 8,513,406 | +1.6% | 0.02% | +12.5% |
Q1 2022 | $202,304,000 | +8.0% | 8,376,942 | +6.4% | 0.02% | +14.3% |
Q4 2021 | $187,331,000 | -5.7% | 7,874,350 | +0.6% | 0.01% | -12.5% |
Q3 2021 | $198,605,000 | +14.5% | 7,828,385 | +1.6% | 0.02% | +14.3% |
Q2 2021 | $173,480,000 | +14.1% | 7,706,809 | +0.1% | 0.01% | +7.7% |
Q1 2021 | $152,059,000 | -25.1% | 7,699,143 | +0.7% | 0.01% | -27.8% |
Q4 2020 | $203,058,000 | -35.5% | 7,642,405 | +19.9% | 0.02% | -43.8% |
Q3 2020 | $314,836,000 | +111.6% | 6,375,763 | +35.5% | 0.03% | +100.0% |
Q2 2020 | $148,780,000 | – | 4,706,759 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |